| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.36 | 0.04 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |